Table 3.
Clinicopathologic variables | HR (95% CI) | P-Value |
---|---|---|
a | ||
Age | 1.056 (1.015-1.100) | 0.008* |
Expression of TRPM4 (Low vs High) | 0.263 (0.098-0.708) | 0.008* |
Clinical stage (Stage I vs Stage IV) | 3.889 (1.024-14.777) | 0.046* |
Tumor grade (G1/G2 vs G3) | 0.540 (0.194-1.502) | 0.238 |
Tumor status (Tumor Free vs With Tumor) | 16.140 (6.043-43.108) | <0.001* |
Lymph node metastasis(Negative vs Positive) | 0.867 (0.106-7.074) | 0.894 |
Myometrial invasion (<50% vs ≥50%) | 1.166 (0.310-4.387) | 0.820 |
Distant metastasis (Negative vs Positive) | 0.661 (0.084-5.224) | 0.695 |
b | ||
Expression of TRPM4 (Low vs High) | 0.332 (0.137-0.804) | 0.015* |
Clinical stage (Stage I vs Stage IV) | 3.165 (1.012-9.904) | 0.048* |
Tumor status (Tumor Free vs With Tumor) | 14.153 (5.480-36.550) | <0.001* |
With significant difference.